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1. Introduction
  Multidrug resistance has been an emerging problem 
clinically, especially for aged and immune compromised 
patients, and additionally neonates with undeveloped 
body physiology have the least capacity against infection 
from multidrug resistant (MDR) pathogens. The production 
of extended spectrum 毬-lactamase (ESBL) is one of 
the important mechanisms of drug resistance and the 
emergence of CTX M 毬-lactamase by Enterobacteriaceae 
has been a matter of clinical concern[1,2]. In due course, 
strains of Klebsiella pneumoniae (K. pneumoniae) have 
emerged with an armamentarium of modifications of outer 
membrane proteins playing crucial role in antibiotic-
efflux mechanisms, generating uncontrollable K. 
pneumoniae strains[3]. A Swedish national was hospitalized 
in New Delhi with infections with K. pneumoniae and 
Escherichia coli (E. coli), and both strains had the plasmid, 
blaNDM-1, which was easily transmitted nosocomially[4]. 
The enzyme, ‘New Delhi 毬-lactamase’ (NDM-1) was 
detected biologically and epidemiologically in patients 
of the Indian sub continent[4].The new, repugnant 
blaNDM-1 gene in the strain of K. pneumoniae was with 
the carbapenamase, consequently resistance to imipenem 
and meropenem (carbapenems) is offered[5]. The infection 
with K. pneumoniae could be a graver problem, because 
it causes bacteremia, pneumonia and septicemia, alike in 
all age groups[6], reported from Germany, for example. The 
underlying mechanism of carbapenem resistance in ESBL 
positive K. pneumoniae isolates is the absence of porin 
channels (Omp K35 or Omp K36) for antibiotic uptake[7], 
combined with AmpC 毬-lactamases for expression of 
carbapenemase[8].
  This report records detection of an infamous strain of 
K. pneumoniae, which has resistance to many commonly 
used drugs, including the rarely used imipenem (IMP). 
Thus, this strain is labeled as metallo 毬-lactamase. By 
the by, the strain was monitored through Vitek 2 system for 
A 10-day old preterm neonate, appropriate for the date, was admitted for lethargy and feeding 
intolerance. By culturing its blood, the antibiogram of the causative bacterium was ascertained 
by both Kirby-Bauer disc diffusion method and the Vitek2 system. Due clinical steps were 
taken for survival of the baby. The baby was suffering from septicemia. The causative bacterium 
was Klebsiella pneumoniae (K. pneumoniae). The isolated strain was found resistant to a total 
of 17 antibiotics; the strain was positive for extended spectrum 毬-lactamase production and 
resistant to two carbapenems, imipenem and meropenem. The baby could not survive. The 
baby was infected with an appalling strain of K. pneumoniae with a capacity to produce metallo 
毬-lactamase overriding carbapenems, which is found to present in the state of Odisha, India.
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confirmation as a MDR pathogen. 
2. Case report
  The second part of a twin, a seven-day old preterm 
(gestational age, GA, 31 weeks) neonate with a low birth 
weight, 1.25 kg, was admitted to our neonatal intensive 
care unit, from a tertiary care hospital for lethargy and 
feeding intolerance. It was ascertained that the neonate 
was neither small for GA nor for date. It was reported that it 
had a normal vaginal delivery in that hospital without any 
perinatal asphyxia, but there was a history of premature 
rupture of membrane (PROM) of around 24 h. Antibiotics 
(cefotaxime and netromycin, for 7 d) and caffeine citrate 
were given to the baby, and gavage feeding was followed 
for further management. On admission, the baby was 
lethargic, normothermic, euglycemic, haemodynamically 
stable, but was with icterus up to palm and sole. Antibiotics 
(piperacillin/tazobactam and gentamicin) were given 
empirically. Further, the baby deteriorated with intermittent 
tonic seizure, apnoea and hypoglycemia. Therefore, anti-
convulsants (lorazepam and phenobarbitone), ionotropes, 
injection vancomycin, and immunoglobulin were given. 
Further, the baby became haemodynamically progressively 
unstable, and eventually it was ventilated in synchronized 
intermittent mandatory ventilation, with pressurized 
oxygen. However, the expected pizzazz was lacking, it was 
slumbering, the rapid deterioration was evident leading 
to an impasse, and death occurred in spite of conflated 
supports. But, the first part of the twin is healthy. 
  Blood counts, electrolytes, bloodgas (ABG) reports and 
chest X-ray picture were normal. There were a high 
billirubin content (total 18 mg/dL, direct 1.8 mg/dL), 
without any sign of kernicterus, high micro-‘erythrocyte 
sedimentation rate’ and C-reactive protein (more than 
7.2 mg/dL). From the blood culture, K. pneumoniae was 
identified, with the help of conventional biochemical 
methods, as per clinical and laboratory standards institute 
(CLSI) guidelines[9]. Moreover, the isolate was identified, in 
parallel by the Vitek 2 system (Biomeriux Vitek system). 
Antibiotic (HiMedia)-susceptibility tests of the isolate were 
performed by the disc-diffusion method according to CLSI 
guidelines, as done before[10], also by the Vitek 2 advanced 
expert system, by which values of minimum inhibitory 
concentration for all antibiotics were determined (Table 
1). Phenotypical detection of ESBL by double disc synergy 
test (DDST) method was done, as described elsewhere[10]. 
For the phenotypical detection of metallo-毬-lactamase, 
the imipenem-EDTA-DDST was done, according to CLSI 
guidelines: the organism was inoculated on to plates with 
Muller-Hinton agar for a lawn culture; an disc of  imipenem 
(10 毺g/disc) was placed at a distance of 20 mm centre to 
centre from a blank disc containing 10 毺L of 0.5 M EDTA. 
Enhancement of the zone of inhibition in the area between 
the imipenem disc and the EDTA disc, in comparison 
with the zone of inhibition on the far side of the disc with 
imipenem was interpreted as the positive result. The K. 
pneumoniae strain was found resistant to 17 antibiotics, 
ESBL-positive and resistant to imipenem and meropenem 
(Table 1). 
Table 1
Antibiogram of the isolated K. pneumoniae strain. 
Antibiotics MIC (毺g/mL) Status
Ampicillin/sulbactam   ≥32 R
Ticarcillin ≥128 R
Piperacillin ≥128 R
Piperacillin/tazobactam ≥128 R
Ceftazidime   ≥64 R
Ceftriaxone   ≥64 R
Cefoperazone/sulbactam ≥128 R
Cefepime   ≥64 R
Imipenem   ≥16 R
Meropenem   ≥16 R
Amikacin   ≥64 R
Gentamicin   ≥16 R
Tobramycin     >16 R
Ciprofloxacin     ≥4 R
Levofloxacin     ≥8 R
Tetracycline   ≥16 R
Trimethoprime/sulfamethoxazole ≥320 R
    Note: R=resistant.
3. Discussion
  Viewed from the trenches of public health, carbapenem 
resistance in an ESBL-positive Gram-negative 
enteropathogenic bacterium infecting neonates is the most 
serious threat from MDR pathogens, ever seen. This is the 
first report from our hospital on carbapenem resistance 
K. pneumoniae. In our hospital, 33.33% ESBL strains of 
P. aeruginosa were reported recently [10]. Virulent MDR 
enteropathogens (Klebsiella, Salmonella, Pseudomonas, 
Shigella, Enterococcus, Vibrio and a few more) are active 
in the non-hygienic poorer communities of developing 
countries; and these are the causative organisms of high 
infant mortality and out-break of infrequent fervent 
episodes[11]. Today, three Gram-negative bacteria 
resistant to all the major classes of antibiotics have 
been emerged and these could be cited as ferocious 
pandrug resistant (PDR) bacteria; more prominently, 
Pseudomonas aeruginosa, Acinetobacter baumannii and 
K. pneumoniae cause utmost comorbidities and frequent 
immature mortality of all age groups[12]. Of course, the 
concept of PDR is not yet consensus in literature, despite 
its clear etymological meanings, ‘resistant to almost 
all commercially available antimicrobials’, ‘resistant 
to all antimicrobials routinely tested’ and ‘resistant to 
all antibiotic classes available for empirical treatment’. 
Moreover, the expression of carbapenemase fortified K. 
pneumoniae as a pathogen and saving a neonate from 
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this PDR strain was abominably intractable, rather was 
exasperating in clinical management.     
The present case, unlike most other cases of under-5 
mortality due to under-nutrition or diarrhoea or 
pneumonia or malaria, is a special case of septicemia by a 
strain of metallo-毬-lactamase K. pneumoniae, prevalent 
in eastern India, which was promoted to the neonate 
probably due to PROM. As known, globally mortality 
rate of neonates has decreased in the last decade, from 
12 million in 1990 to 6.9 million in 2011, recorded in a 
WHO estimate[13,14], and this country has 24% of under-5 
death, and India is one among 5 leading countries of 
under-5 mortality. Levels and trends of under-5 mortality 
and survival of infants as well as neonate have been 
decreasing worldwide, but in several developing countries 
the levels are still higher[15-17]. But, infant mortality rates, 
35% in Sub-Saharan African, 45% in Eastern and Southern 
Africa, 28% in West and Central Africa, 48% in Middle 
East and North Africa, 43% in South Asia, 59% in East Asia 
and Pacific, 61% in Latin America and Caribbean, 56% 
in Central Eastern Europe/Commonwealth Independent 
States were recorded, whereas the world figure was 39%[18]. 
Conflict of interest
   The authors declare they have no conflict of interests.
Acknowledgements
  D Dubey is a INSPIRE Fellow, DST, Govt. of India, 
New Delhi. RN Padhy is a Scientist from CSIR, Govt. of 
India, New Delhi. We are grateful to Dr. DK Roy, Dean, 
and Shri Gopabandhu Kar, Managing Member, IMS & 
SUM Hospital, Siksha ‘O’ Anusandhan University for the 
extended facilities and encouragements.
References
[1]   Livermore DM, Hawkey PM. CTX M Changing the face of 
ESBLs in UK. J Antimicrob Chemother 2005; 56: 451-454. 
[2]   Sharma M, Yadav S, Chaudhary U. Metallo-beta-lactamase 
producing Pseudomonas aeruginosa in neonatal septicemia. J 
Lab Physicians 2010; 2: 14-16.
[3]   Hentschke M, Wolters M, Sobottka I, Rohde H, Aepfelbacher 
M. ramR mutations in clinical isolates of Klebsiella pneumoniae 
with reduced susceptibility to tigecycline. Antimicrob Agents 
Chemother 2010; 54: 2720-2723.
[4]   Peirano G, Ahmed-Bentley J, Woodford N, Pitou JD. New 
Delhi metallo-毬-lactamase from traveler returning to Canada. 
Emerg Infect Dis 2011: 17: 242-244.
[5]   Yong D, Toleman MA, Giske CG, et al. Characterization of 
a new metallo-毬-lactamase gene, blaNDM-1, and a novel 
erythromycin esterase gene carried on a unique genetic 
structure in Klebsiella pneumoniae sequence type 14 from 
India. Antimicrob Agents Chemother 2009; 53: 5046-5054.
[6]   Grobner S, Linke D, Schutz W, Fladerer C, Madlung J, 
Autenriet IB, et al. Emergence of carbapenem-non-susceptible 
extended-spectrum-毬-lactamase-producing Klebsiella 
pneumoniae isolates at the university hospital of Tubingen, 
Germany. J Med Microbiol 2009; 58: 912-922.
[7]   Martinez-Martinez L, Pascual A, Herna´ndez-Alle´s, S, 
Alvarez-Dı´a, D, Sua´rez AI, et al. Roles of 毬-lactamase and 
porins in activities of carbapenems and cephalosporins against 
Klebsiella pneumoniae.  Antimicrob Agents Chemother 1999; 43: 
1669-1673.
[8]   Woodford N, Tierno PM, Jr Young K, Tysall L, Palepou MF, 
Ward, E, Painter RE, et al. Outbreak of Klebsiella pneumoniae 
producing a new carbapenem-hydrolyzing class A 毬
-lactamase, KPC-3, in a New York Medical Center. Antimicrob 
Agents Chemother 2004; 48: 4793-4799.
[9]   Clinical and Laboratory Standards Institute. Performance 
standard for antimicrobial susceptibility testing: twenty-first 
informational supplement. Document M200-S21; Wayne; 2011.
[10] Sahu MC, S Rath S, D Dubey D, Debata NK, Padhy RN. 
Multidrug resistance of Pseudomonas aeruginosa as known 
from surveillance of nosocomial and community infections in an 
Indian teaching hospital. J Publ Health 2012; 20: 413-423.
[11] Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative 
bacteria: the dawn of the post-antibiotic era? Int J Antimicrob 
Agents 2007; 29: 630-636.
[12] Burgos JM, Ellington BA, Varela MF. Presence of multidrug-
resistant enteric bacteria in dairy farm topsoil. J Dairy Sci 
2005; 88: 1391-1398.
[13] Bryce J, Boschi-Pinto C, Shibuya K, Black RE, the WHO 
Child  Health Epidemiology Reference Group. WHO estimates 
of the causes of death in children. Lancet 2005; 365: 1147-
1152
[14] UNICEF. Committing to child survival: a promise renewed. 
UNICEF Progress report, 2012. 
[15] Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N, 
de Bernis L, For the Lancet neonatal survival steering team. 
Evidence-based, cost-effective interventions: how many 
newborn babies can we save? Lancet 2005; 365: 977-988. 
[16] You D, Wardlaw T, Salama P, Jones G. Levels and trends in 
under-5 mortality, 1990-2008. Lancet 2010; 375: 100-103.
[17] Sarangi R. Study on under-five mortality profile in hospitalized 
children. MD thesis. Berhampur University 2006. 1-100 + 
appendix. 
[18] Anonymous. Trends in infant mortality, 1960-2011[Online]. 
Available from: www.childinfo.org/mortality_imrcountrydata.
php. [Accessed on Sep, 2012].
